Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Minden – page 8

115 clinical trials in Minden, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Minden at a glance
115
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

115 trials in Minden

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enasidenib Mesilate
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Heidelberg University
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol Myers Squibb International Corporation
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR

Breast cancer+3

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Celgene Corp.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mogamulizumab
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Io102 Hydrochloride
  • Sponsor:Io Biotech ApS
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Busulfan
  • Sponsor:Celgene Corp.

Colitis ulcerative

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Pfizer Inc.

Other cities in Germany

The busiest research cities in the country

All 516 cities in Germany

Clinical research in Minden

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on various forms of blood cancers and solid tumors, including innovative treatments for acute myeloid leukemia, lymphomas, and melanoma. Studies evaluating combination therapies and novel drug approaches for improved patient outcomes.

  • Hematologic Malignancies
  • Solid Tumors
  • Immunotherapy

Several trials investigating targeted therapies and immunological approaches for breast cancer and basal cell carcinoma.

02 Autoimmune Conditions

Clinical investigations targeting systemic sclerosis, psoriatic arthritis, and other autoimmune disorders. Research focused on developing new biological treatments and evaluating their effectiveness in managing disease progression.

  • Rheumatic Diseases
  • Inflammatory Conditions
  • Novel Biologics

Studies examining innovative treatments for interstitial lung diseases associated with rheumatic conditions.

03 Neurological & Sensory Disorders

Research initiatives examining treatments for acute cerebral ischemic stroke and sudden hearing loss. Studies evaluating new therapeutic approaches to improve patient outcomes and quality of life.

  • Stroke Management
  • Auditory Disorders
  • Therapeutic Innovation

Trials testing novel compounds and treatment strategies for various neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.